Recurrent embolic stroke associated with adenomyosis: A single case report and literature review

case-report OA: closed CC0 ⤵ 4 in-corpus citations
⚙ AI-generated summary by gemini-2.5-flash-lite+body, 2026-06-10 ⓘ

This study reports a cerebral infarction case associated with adenomyosis and reviews 19 cases, finding patients were young, strokes occurred during menstruation, and hysterectomy prevented recurrence unlike antithrombotic therapy.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-07 · read from full text ⓘ

This paper reports a 42-year-old woman with previously diagnosed uterine adenomyosis who developed multiple recurrent embolic cerebral infarctions during menstruation, along with a systematic PubMed literature review. She had elevated CA125 (293 U/mL rising to 743 U/mL on readmission) and recurrent stroke occurred despite starting edoxaban shortly before her subsequent menstrual period; hysterectomy was then performed with no further recurrences reported. In the review of 19 total reported cases, stroke typically occurred during menstruation (85%), involved multiple infarctions across at least three vessel territories (39%), and showed high CA125 and D-dimer levels; antithrombotic therapy was used in 14 patients but recurrent stroke still occurred in 36%, while hysterectomy was associated with no further recurrences in the subset reported. This paper is centrally about adenomyosis — it describes recurrent embolic stroke temporally associated with menstruation and reviews prior cases of cerebral infarction linked to adenomyosis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

INTRODUCTION: Uterine adenomyosis is a benign disorder in which endometrial glands and stroma are present within the myometrium. There have been several case reports of cerebral infarction associated with adenomyosis, but their clinical characteristics, optimal treatment, and prognosis have not been systematically reviewed. METHODS: A case of cerebral infarction with adenomyosis is reported, and a comprehensive systematic literature search using the PubMed database was conducted. RESULTS: A 42-year-old woman, previously diagnosed with adenomyosis, developed multiple cerebral infarctions during menstruation. Her CA125 level was 293 U/mL, and treatment with edoxaban 30 mg was started. Seven days after hospital discharge, she had her subsequent menstrual period and then developed a recurrent stroke. Her CA125 level was 743 U/mL on readmission. A hysterectomy was performed, and the patient has had no further stroke recurrence. A systematic review identified 19 cases with cerebral infarction associated with adenomyosis, including the present case. The patients' clinical characteristics included young age (44.7 ± 6.2 years), stroke development during menstruation (85%), multiple infarctions affecting ≥ 3 vessel territories (39%), and high levels of CA125 and D-dimer (810.6 ± 888.4 U/mL, and 10.3 ± 18.6 μg/mL, respectively). Antithrombotic therapy was given to 14 patients, but recurrent stroke occurred in 5 (36%) patients. Hysterectomy was conducted in 5 and 4 patients with initial and recurrent stokes, respectively, and there were no further recurrences thereafter. CONCLUSION: Cerebral infarction associated with adenomyosis has specific clinical characteristics. Antithrombotic therapy was insufficient, and hysterectomy should particularly be considered in cases of recurrent stroke.
Full text 9,335 characters · extracted from oa-doi-fallback · 5 sections · click to expand

Abstract

Introduction Uterine adenomyosis is a benign disorder in which endometrial glands and stroma are present within the myometrium. There have been several case reports of cerebral infarction associated with adenomyosis, but their clinical characteristics, optimal treatment, and prognosis have not been systematically reviewed.

Methods

A case of cerebral infarction with adenomyosis is reported, and a comprehensive systematic literature search using the PubMed database was conducted.

Results

A 42-year-old woman, previously diagnosed with adenomyosis, developed multiple cerebral infarctions during menstruation. Her CA125 level was 293 U/mL, and treatment with edoxaban 30 mg was started. Seven days after hospital discharge, she had her subsequent menstrual period and then developed a recurrent stroke. Her CA125 level was 743 U/mL on readmission. A hysterectomy was performed, and the patient has had no further stroke recurrence. A systematic review identified 19 cases with cerebral infarction associated with adenomyosis, including the present case. The patients’ clinical characteristics included young age (44.7 ± 6.2 years), stroke development during menstruation (85%), multiple infarctions affecting ≥ 3 vessel territories (39%), and high levels of CA125 and D-dimer (810.6 ± 888.4 U/mL, and 10.3 ± 18.6 μg/mL, respectively). Antithrombotic therapy was given to 14 patients, but recurrent stroke occurred in 5 (36%) patients. Hysterectomy was conducted in 5 and 4 patients with initial and recurrent stokes, respectively, and there were no further recurrences thereafter.

Conclusion

Cerebral infarction associated with adenomyosis has specific clinical characteristics. Antithrombotic therapy was insufficient, and hysterectomy should particularly be considered in cases of recurrent stroke. Similar content being viewed by others

References

Hong EY, Lin HZ, Fong YF (2020) Venous Thromboembolism and Adenomyosis: A Retrospective Review. Gynecol Minim Invasive Ther 9(2):64–68. https://doi.org/10.4103/GMIT.GMIT_77_19 Yin X, Wu J, Song S, Zhang B, Chen Y (2018) Cerebral infarcts associated with adenomyosis: a rare risk factor for stroke in middle-aged women: a case series. BMC Neurol 18(1):213. https://doi.org/10.1186/s12883-018-1213-2 Yasuda M, Yamanaka Y, Kano H, Araki N, Ishikawa H, Ikeda JI, Kuwabara S (2022) Recurrent Cerebral Infarcts Associated with Uterine Adenomyosis: Successful Prevention by Surgical Removal. Intern Med 61(5):735–738. https://doi.org/10.2169/internalmedicine.7320-21 Aso Y, Chikazawa R, Kimura Y, Kimura N, Matsubara E (2018) Recurrent multiple cerebral infarctions related to the progression of adenomyosis: a case report. BMC Neurol 18(1):119. https://doi.org/10.1186/s12883-018-1117-1 Yamashiro K, Tanaka R, Nishioka K, Ueno Y, Shimura H, Okuma Y, Hattori N, Urabe T (2012) Cerebral infarcts associated with adenomyosis among middle-aged women. J Stroke Cerebrovasc Dis 21 (8):910 e911–915. https://doi.org/10.1016/j.jstrokecerebrovasdis.2011.10.017 Okazaki K, Oka F, Ishihara H, Suzuki M (2018) Cerebral infarction associated with benign mucin-producing adenomyosis: report of two cases. BMC Neurol 18(1):166. https://doi.org/10.1186/s12883-018-1169-2 Arai N, Yachi K, Ishihara R, Fukushima T (2022) Adenomyosis-associated recurrent acute cerebral infarction mimicking Trousseau’s syndrome: A case study and review of literature. Surg Neurol Int 13:179. https://doi.org/10.25259/SNI_252_2022 Zhao Y, Zhang Y, Yang Y (2020) Acute cerebral infarction with adenomyosis in a patient with fever: a case report. BMC Neurol 20(1):210. https://doi.org/10.1186/s12883-020-01787-0 Kim B, Kim SH, Kim T (2018) Cerebral Infarcts by Nonbacterial Thrombotic Endocarditis Associated with Adenomyosis: A Case Report. J Stroke Cerebrovasc Dis 27(3):e50–e53. https://doi.org/10.1016/j.jstrokecerebrovasdis.2017.10.005 Aiura R, Nakayama S, Yamaga H, Kato Y, Fujishima H (2021) Systemic thromboembolism including multiple cerebral infarctions with middle cerebral artery occlusion caused by the progression of adenomyosis with benign gynecological tumor: a case report. BMC Neurol 21(1):14. https://doi.org/10.1186/s12883-021-02045-7 Zhang S, Zhao LM, Xue BQ, Liang H, Guo GC, Liu Y, Wu RY, Li CY (2022) Acute recurrent cerebral infarction caused by moyamoya disease complicated with adenomyosis: A case report. World J Clin Cases 10(14):4617–4624. https://doi.org/10.12998/wjcc.v10.i14.4617 Hijikata N, Sakamoto Y, Nito C, Matsumoto N, Abe A, Nogami A, Sato T, Hokama H, Okubo S, Kimura K (2016) Multiple Cerebral Infarctions in a Patient with Adenomyosis on Hormone Replacement Therapy: A Case Report. J Stroke Cerebrovasc Dis 25(10):e183-184. https://doi.org/10.1016/j.jstrokecerebrovasdis.2016.07.024 Uchino K, Shimizu T, Mizukami H, Isahaya K, Ogura H, Shinohara K, Hasegawa Y (2018) Nonbacterial Thrombotic Endocarditis Complicated by Cerebral Infarction in a Patient with Adenomyosis with High Serum CA125 Level; A Case Report. J Stroke Cerebrovasc Dis 27(3):e42–e45. https://doi.org/10.1016/j.jstrokecerebrovasdis.2017.09.064 Hirsh J, Anand SS, Halperin JL, Fuster V (2001) Mechanism of action and pharmacology of unfractionated heparin. Arterioscler Thromb Vasc Biol 21(7):1094–1096. https://doi.org/10.1161/hq0701.093686 Edaravone Acute Infarction Study G (2003) Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters. Cerebrovasc Dis 15 (3):222–229. https://doi.org/10.1159/000069318 Miyamoto S, Ogasawara K, Kuroda S, Itabashi R, Toyoda K, Itoh Y, Iguchi Y, Shiokawa Y, Takagi Y, Ohtsuki T, Kinouchi H, Okada Y, Takahashi JC, Nakase H, Kakuda W, Committee for Stroke Guideline tJSS, (2022) Japan Stroke Society Guideline 2021 for the Treatment of Stroke. Int J Stroke 17(9):1039–1049. https://doi.org/10.1177/17474930221090347 Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, Waldo AL, Ezekowitz MD, Weitz JI, Spinar J, Ruzyllo W, Ruda M, Koretsune Y, Betcher J, Shi M, Grip LT, Patel SP, Patel I, Hanyok JJ, Mercuri M, Antman EM, Investigators EA-T (2013) Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med 369(22):2093–2104. https://doi.org/10.1056/NEJMoa1310907 Nouh AM, Staff I, Finelli PF (2019) Three Territory Sign: An MRI marker of malignancy-related ischemic stroke (Trousseau syndrome). Neurol Clin Pract 9(2):124–128. https://doi.org/10.1212/CPJ.0000000000000603 Morassutto C, Monasta L, Ricci G, Barbone F, Ronfani L (2016) Incidence and Estimated Prevalence of Endometriosis and Adenomyosis in Northeast Italy: A Data Linkage Study. PLoS One 11 (4):e0154227. https://doi.org/10.1371/journal.pone.0154227 Upson K, Missmer SA (2020) Epidemiology of Adenomyosis. Semin Reprod Med 38(2–03):89–107. https://doi.org/10.1055/s-0040-1718920 Fukamatsu Y, Tsukahara Y, Fukuta T (1984) A clinicopathologic study on adenomyosis uteri. Nihon Sanka Fujinka Gakkai Zasshi 36(3):431–436 Varki A (2007) Trousseau’s syndrome: multiple definitions and multiple mechanisms. Blood 110(6):1723–1729. https://doi.org/10.1182/blood-2006-10-053736 Kan YY, Yeh SH, Ng HT, Lou CM (1992) Effect of menstruation on serum CA125 levels. Asia Oceania J Obstet Gynaecol 18(4):339–343. https://doi.org/10.1111/j.1447-0756.1992.tb00329.x Levgur M (2007) Therapeutic options for adenomyosis: a review. Arch Gynecol Obstet 276(1):1–15. https://doi.org/10.1007/s00404-006-0299-8 Fujishita A, Masuzaki H, Khan KN, Kitajima M, Ishimaru T (2004) Modified reduction surgery for adenomyosis. A preliminary report of the transverse H incision technique. Gynecol Obstet Invest 57 (3):132–138. https://doi.org/10.1159/000075830 Nishioka K, Tanaka R, Tsutsumi S, Yamashiro K, Nakahara M, Shimura H, Hattori N, Urabe T (2014) Cerebral dural sinus thrombosis associated with adenomyosis: a case report. J Stroke Cerebrovasc Dis 23(7):1985–1987. https://doi.org/10.1016/j.jstrokecerebrovasdis.2014.01.027 Funding This work was partly supported by JSPS KAKENHI (Grant Number JP20K07909). Author information Authors and Affiliations Corresponding author Ethics declarations Conflicts of interest YU received lecture fees from OHARA Pharmaceutical Co., Ltd., and research funds from Bristol-Myers Squibb. The other authors declare no potential conflicts of interest. Ethical approval Not applicable. Informed consent Written, informed consent was obtained from the patient included in the study. Additional information Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Rights and permissions Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. About this article Cite this article Morishima, Y., Ueno, Y., Satake, A. et al. Recurrent embolic stroke associated with adenomyosis: A single case report and literature review. Neurol Sci 44, 2421–2429 (2023). https://doi.org/10.1007/s10072-023-06701-3 Received: Accepted: Published: Version of record: Issue date: DOI: https://doi.org/10.1007/s10072-023-06701-3

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

adenomyosis

MeSH descriptors

Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (26)

Cited by (4)

Source provenance

europepmc
last seen: 2026-10-03T06:16:46.921020+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-03T06:16:01.715363+00:00
License: CC0 · commercial use OK